The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Forecasted Rise In Market Size Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market During The Forecast Period?
The market size for pharmaceutical contract development and manufacturing organizations (CMOs) has experienced rapid expansion in recent years. This market is projected to expand from $54.73 billion in 2025 to $60.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this expansion can be linked to factors such as increased research and development (R&D) investments by drug companies, a surge in chronic disease cases, higher demand for generic drugs, breakthroughs in drug manufacturing technology, and an enhanced emphasis on preclinical and clinical investigations.
The pharmaceutical contract development and manufacturing organization (cmo) market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $90.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. This expansion over the forecast period is driven by factors such as the increasing uptake of personalized medicine, the rising demand for biologics and complex therapeutics, the broadening of CDMO capabilities in nascent markets, the incorporation of digital technologies into drug development processes, and a surge in strategic alliances and mergers across the pharmaceutical sector. Prominent trends expected during this period involve the outsourcing of drug development and manufacturing activities, an expansion of CDMO service offerings, a sharpened focus on regulatory adherence and quality assurance, the formation of strategic collaborations between pharmaceutical companies and CDMOs, and the implementation of advanced analytical and testing services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Which Growth Factors Are Strengthening The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Landscape?
The growing number of expiring patents is anticipated to boost the pharmaceutical contract development and manufacturing market. Patent expiration denotes the termination of legal exclusive entitlements allowing an inventor or patent owner to manufacture, distribute, or utilize an invention for a set duration. Services in pharmaceutical contract development and manufacturing facilitate the rapid creation and manufacturing of generic medications, enabling their market introduction once patents expire. For instance, in February 2024, as reported by DrugTimes, a Chinese-based company focused on the pharmaceutical and biotech industry, it is anticipated that by 2037, more than 25 products will lose patent protection, potentially resulting in a combined revenue decline exceeding $236.4 billion, based on 2024 sales. Consequently, the expanding rate of patent expiration is propelling the pharmaceutical contract development and manufacturing market.
Which Segment Divisions Form The Structure Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
3) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
What Trends Are Shaping The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Structure?
Major companies operating in the pharmaceutical contract development and manufacturing market are introducing new services such as the DevPack to enhance their service portfolios and address the evolving needs of the industry. The DevPack is a service optimized among multiple partners to create a standardized dataset of development process steps. For instance, in May 2023, ASM Research Chemicals, a Germany-based company providing contract research and manufacturing services, launched DevPack, a novel development pack service intended for active pharmaceutical ingredients (APIs) manufacturing. This specific DevPack service, optimized across ten core partners, offers a standardized dataset for development processes. It assists in streamlining API research, development, and scale-up. Being an ideal solution for CMOs and pharmaceutical firms aiming for quick early-stage manufacturing route development for APIs, the service also supports analytical development and regulatory submissions.
Who Are The Businesses Driving Activity In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market are Lonza Group, Catalent Inc, WuXi AppTec Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Access The Complete Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report:
Which Region Has The Strongest Presence In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model